Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
TOLREMO therapeutics
156
TOLREMO therapeutics
Health Care
Medical
Therapeutics
TOLREMO therapeutics AG is an ETH spinoff focused on the discovery and development of small molecules to prevent resistance in cancer therapy.
Suggest edits
Raised
$9.3M
Follow us
Also headquartered in Zurich
UBS
Avaloq
ETH Zurich
Tresorit
digitalMedLab Ltd.
Scandit
AirConsole
BinaryEdge
Ava
Ping
Companies in the same industry
Padlock Therapeutics
Kona Medical, Inc.
Prosensa
ElectroCore
Silence Therapeutics
FLX Bio, Inc.
Evox Therapeutics Ltd
Hengrui Therapeutics, Inc.
numares AG
Brainvectis
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Add round
24 Sep
2018
$9,300,000
Venture capital (Series A)
BioMedPartners
Tolremo Raises CHF9.0M in Series A Funding
FinSMEs